PMS (Premenstrual Syndrome): The Evidence-Based Supplement Protocol

← Back to articles

Premenstrual syndrome (PMS) is the regular, cycle-linked cluster of physical and mood symptoms that show up in the luteal phase (the roughly two weeks before a period) and clear within a few days of the period starting. Mild premenstrual symptoms affect most people who menstruate; clinically significant PMS affects a smaller fraction, and premenstrual dysphoric disorder (PMDD) is the severe, formally diagnosed version covered in a separate protocol. The supplement evidence below is graded by trial quality. Confirm a true luteal-phase pattern with two cycles of daily symptom tracking before attributing anything to a treatment, because placebo response in PMS trials is consistently large (often 30–40%).

Calcium — Best Evidence (Moderate)

Calcium carries the strongest randomized evidence of any supplement in PMS. In a multicenter, double-blind RCT of 466 evaluable women, calcium carbonate 1,200 mg/day of elemental calcium produced a 48% reduction in total luteal-phase symptom score by the third treatment cycle versus 30% on placebo, with significant improvement across negative affect, water retention, food cravings, and pain (Thys-Jacobs 1998). An earlier crossover trial by the same group found 73% of women preferred calcium to placebo (Thys-Jacobs 1989). A 2025 systematic review of nutritional interventions and a 2003 review of CAM therapies both identified calcium as having the most consistent positive signal for PMS. Typical dose: 1,000–1,200 mg elemental calcium daily, ideally split and taken with food. Cautions: high supplemental calcium has been associated with kidney stones and, in some cohorts, cardiovascular concerns; prioritize dietary calcium and do not exceed the tolerable upper intake. See our calcium piece.

Chasteberry / Vitex — Moderate Evidence

Chasteberry (Vitex agnus-castus) is the best-studied herb for PMS. A landmark double-blind RCT of 170 women using the standardized extract Ze 440 found a responder rate (≥50% symptom reduction) of 52% versus 24% on placebo over three cycles (Schellenberg 2001). Two systematic reviews — eight RCTs (Cerqueira 2017) and thirteen RCTs (van Die 2012) — concluded that most trials favored Vitex over placebo, with the effect most reliable for breast tenderness (mastalgia) and irritability, plausibly via dopaminergic suppression of prolactin. Trial quality is moderate and several studies were industry-funded. Typical dose: a standardized fruit extract equivalent to ~20–40 mg dried fruit daily. Cautions: because Vitex acts on dopamine and prolactin pathways, avoid combining it with dopaminergic agents, antipsychotics, or hormonal contraceptives without clinician oversight, and do not use in pregnancy. Vitex does not have a resolving SupplementScore entry, so it is intentionally left unlinked here.

Vitamin B6 — Limited-to-Moderate Evidence

A systematic review of nine placebo-controlled trials (940 women) found vitamin B6 roughly doubled the odds of overall symptom improvement (odds ratio 2.32, 95% CI 1.95–2.54) and improved depressive symptoms (OR 1.69), while explicitly noting that most included trials were low quality (Wyatt 1999). The 2025 nutritional-intervention review likewise rated B6 among the more consistent agents for psychological symptoms. Typical dose: 50–100 mg/day. Critical caution: chronic high-dose B6 can cause a dose-dependent sensory peripheral neuropathy. Stay at or below 100 mg/day, and stop if you develop numbness or tingling in the hands or feet.

Saffron — Limited Evidence (Mood-Predominant PMS)

A double-blind RCT of women with PMS found saffron (Crocus sativus) 30 mg/day significantly improved both the Total Premenstrual Daily Symptoms score and the Hamilton Depression Rating Scale versus placebo over two cycles (Agha-Hosseini 2008). This is a single, relatively small trial, so the evidence is limited, but saffron is a reasonable option when low mood dominates the symptom picture. Typical dose: 30 mg/day of a standardized stigma extract. Cautions: avoid in pregnancy; theoretical additive effect with serotonergic antidepressants. See our saffron piece.

Magnesium — Insufficient / Inconsistent Evidence

Despite its popularity, the controlled evidence for magnesium in PMS is weak. Small early trials suggested benefit for fluid retention and mood, but the 2025 systematic review of randomized trials concluded there was insufficient evidence to support magnesium for psychological PMS symptoms. It is low-risk and may help individuals with marginal intake or coexisting menstrual migraine, but it should not be presented as well-established. Typical dose: 200–360 mg elemental daily; well-absorbed forms such as magnesium glycinate are gentler on the gut. Caution: diarrhea at higher doses; reduce in renal impairment.

What Doesn't Work / Overhyped

Avoid evening primrose oil for general PMS — controlled data do not support it beyond a possible small effect on breast tenderness. Skip "menstrual support" or "hormone balance" megaformulas that combine ten or more sub-clinical-dose ingredients; doses are typically too low to match the trials above, and stacking multiple botanicals makes adverse effects and attribution impossible. Avoid diuretic "water pill" supplements — reducing dietary sodium in the luteal phase is safer and at least as effective. Do not combine several herbal hormone modulators at once (for example Vitex plus dong quai plus black cohosh plus soy); the interaction profile is unknown and dong quai may increase bleeding.

How to Run the Protocol

First, confirm the diagnosis: track symptoms daily across two cycles to verify they cluster in the luteal phase and clear after menses. Build the foundation with lifestyle measures that have independent evidence — regular aerobic exercise, adequate sleep, and a lower-sodium, lower-refined-carbohydrate diet. For supplements, start with the best-evidenced single agent rather than a stack: calcium 1,000–1,200 mg/day. If symptoms remain bothersome, add a standardized chasteberry extract for at least three cycles (best for breast tenderness and irritability), or B6 up to 100 mg/day. Reserve saffron 30 mg/day for mood-predominant presentations. Introduce one agent at a time so you can judge what actually helps. If symptoms are severe, meet PMDD criteria, or significantly impair functioning, an SSRI (continuous or luteal-phase dosing) or hormonal therapy is more effective than any supplement — see the separate PMDD protocol and discuss options with a clinician.